Derynck Mika K
Director
Exercise
Calculated transaction value
$346.96K
23,364 shares @ $14.85
Traded
Aug 4, 2026
Filed
Aug 6, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Enliven Therapeutics
ELVN
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
74 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Derynck Mika K Director | Aug 6, 2026 2-day lag | Exercise Aug 4, 2026 | $346.96K Filed shares x price | SEC Form 4 View filing | |
| Derynck Mika K Director | Aug 6, 2026 2-day lag | Exercise Aug 4, 2026 | $696.89K Filed shares x price | SEC Form 4 View filing | |
| Derynck Mika K Director | Aug 6, 2026 2-day lag | Exercise Aug 4, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Derynck Mika K Director | Aug 6, 2026 2-day lag | Exercise Aug 4, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Derynck Mika K Director | Aug 6, 2026 2-day lag | Sale Aug 4, 2026 | $9.56M Filed shares x price | SEC Form 4 View filing | |
| Derynck Mika K Director | Aug 6, 2026 2-day lag | Exercise Aug 4, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Derynck Mika K Director | Aug 6, 2026 2-day lag | Exercise Aug 4, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Derynck Mika K Director | Aug 6, 2026 2-day lag | Exercise Aug 4, 2026 | $460.43K Filed shares x price | SEC Form 4 View filing | |
| Derynck Mika K Director | Aug 6, 2026 2-day lag | Exercise Aug 4, 2026 | $216.69K Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Jul 21, 2026 4-day lag | Sale Jul 17, 2026 | $140.82K Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Jul 21, 2026 4-day lag | Sale Jul 17, 2026 | $19K Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Jul 21, 2026 4-day lag | Sale Jul 17, 2026 | $6.63K Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Jul 21, 2026 4-day lag | Exercise Jul 17, 2026 | $2.66K Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Jul 21, 2026 4-day lag | Sale Jul 17, 2026 | $16.19K Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Jul 21, 2026 4-day lag | Exercise Jul 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Jul 21, 2026 4-day lag | Sale Jul 17, 2026 | $134.14K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Jul 21, 2026 4-day lag | Exercise Jul 17, 2026 | $12.4K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Jul 21, 2026 4-day lag | Exercise Jul 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Jul 21, 2026 4-day lag | Sale Jul 17, 2026 | $3.4K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Jul 21, 2026 4-day lag | Sale Jul 17, 2026 | $108.08K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Jul 21, 2026 4-day lag | Sale Jul 17, 2026 | $116.67K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Jul 21, 2026 4-day lag | Sale Jul 17, 2026 | $23.66K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Jul 21, 2026 4-day lag | Sale Jul 17, 2026 | $11.56K Filed shares x price | SEC Form 4 View filing | |
| Kunkel Lori Anne Director | Jul 8, 2026 2-day lag | Sale Jul 6, 2026 | $299.42K Filed shares x price | SEC Form 4 View filing | |
| Kunkel Lori Anne Director | Jul 8, 2026 2-day lag | Sale Jul 6, 2026 | $205.48K Filed shares x price | SEC Form 4 View filing | |
| Orbimed Advisors Llc 10% owner | Jun 24, 2026 2-day lag | Sale Jun 22, 2026 | $66.47K Filed shares x price | SEC Form 4 View filing | |
| Orbimed Advisors Llc 10% owner | Jun 24, 2026 2-day lag | Sale Jun 22, 2026 | $2.1M Filed shares x price | SEC Form 4 View filing | |
| Orbimed Advisors Llc 10% owner | Jun 24, 2026 2-day lag | Sale Jun 22, 2026 | $1.13M Filed shares x price | SEC Form 4 View filing | |
| Orbimed Advisors Llc 10% owner | Jun 24, 2026 2-day lag | Sale Jun 22, 2026 | $35.72M Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Jun 22, 2026 5-day lag | Sale Jun 17, 2026 | $114.02K Filed shares x price | SEC Form 4 View filing |
Derynck Mika K
Director
Exercise
Calculated transaction value
$696.89K
27,567 shares @ $25.28
Traded
Aug 4, 2026
Filed
Aug 6, 2026
Derynck Mika K
Director
Exercise
Calculated transaction value
$0
20,491 shares @ $0
Traded
Aug 4, 2026
Filed
Aug 6, 2026
Derynck Mika K
Director
Exercise
Calculated transaction value
$0
27,567 shares @ $0
Traded
Aug 4, 2026
Filed
Aug 6, 2026
Derynck Mika K
Director
Sale
Calculated transaction value
$9.56M
158,795 shares @ $60.21
Traded
Aug 4, 2026
Filed
Aug 6, 2026
Derynck Mika K
Director
Exercise
Calculated transaction value
$0
23,364 shares @ $0
Traded
Aug 4, 2026
Filed
Aug 6, 2026
Derynck Mika K
Director
Exercise
Calculated transaction value
$0
87,373 shares @ $0
Traded
Aug 4, 2026
Filed
Aug 6, 2026
Derynck Mika K
Director
Exercise
Calculated transaction value
$460.43K
20,491 shares @ $22.47
Traded
Aug 4, 2026
Filed
Aug 6, 2026
Derynck Mika K
Director
Exercise
Calculated transaction value
$216.69K
87,373 shares @ $2.48
Traded
Aug 4, 2026
Filed
Aug 6, 2026
Hohl Benjamin
Chief Financial Officer
Sale
Calculated transaction value
$140.82K
2,638 shares @ $53.38
Traded
Jul 17, 2026
Filed
Jul 21, 2026
Hohl Benjamin
Chief Financial Officer
Sale
Calculated transaction value
$19K
369 shares @ $51.48
Traded
Jul 17, 2026
Filed
Jul 21, 2026
Hohl Benjamin
Chief Financial Officer
Sale
Calculated transaction value
$6.63K
123 shares @ $53.87
Traded
Jul 17, 2026
Filed
Jul 21, 2026
Hohl Benjamin
Chief Financial Officer
Exercise
Calculated transaction value
$2.66K
1,072 shares @ $2.48
Traded
Jul 17, 2026
Filed
Jul 21, 2026
Hohl Benjamin
Chief Financial Officer
Sale
Calculated transaction value
$16.19K
324 shares @ $49.97
Traded
Jul 17, 2026
Filed
Jul 21, 2026
Hohl Benjamin
Chief Financial Officer
Exercise
Calculated transaction value
$0
1,072 shares @ $0
Traded
Jul 17, 2026
Filed
Jul 21, 2026
Hohl Benjamin
Chief Financial Officer
Sale
Calculated transaction value
$134.14K
2,564 shares @ $52.32
Traded
Jul 17, 2026
Filed
Jul 21, 2026
Collins Helen Louise
Chief Medical Officer
Exercise
Calculated transaction value
$12.4K
5,000 shares @ $2.48
Traded
Jul 17, 2026
Filed
Jul 21, 2026
Collins Helen Louise
Chief Medical Officer
Exercise
Calculated transaction value
$0
5,000 shares @ $0
Traded
Jul 17, 2026
Filed
Jul 21, 2026
Collins Helen Louise
Chief Medical Officer
Sale
Calculated transaction value
$3.4K
63 shares @ $53.92
Traded
Jul 17, 2026
Filed
Jul 21, 2026
Collins Helen Louise
Chief Medical Officer
Sale
Calculated transaction value
$108.08K
2,063 shares @ $52.39
Traded
Jul 17, 2026
Filed
Jul 21, 2026
Collins Helen Louise
Chief Medical Officer
Sale
Calculated transaction value
$116.67K
2,184 shares @ $53.42
Traded
Jul 17, 2026
Filed
Jul 21, 2026
Collins Helen Louise
Chief Medical Officer
Sale
Calculated transaction value
$23.66K
459 shares @ $51.55
Traded
Jul 17, 2026
Filed
Jul 21, 2026
Collins Helen Louise
Chief Medical Officer
Sale
Calculated transaction value
$11.56K
231 shares @ $50.05
Traded
Jul 17, 2026
Filed
Jul 21, 2026
Kunkel Lori Anne
Director
Sale
Calculated transaction value
$299.42K
5,889 shares @ $50.84
Traded
Jul 6, 2026
Filed
Jul 8, 2026
Kunkel Lori Anne
Director
Sale
Calculated transaction value
$205.48K
4,111 shares @ $49.98
Traded
Jul 6, 2026
Filed
Jul 8, 2026
Orbimed Advisors Llc
10% owner
Sale
Calculated transaction value
$66.47K
1,477 shares @ $45
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Orbimed Advisors Llc
10% owner
Sale
Calculated transaction value
$2.1M
46,776 shares @ $45
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Orbimed Advisors Llc
10% owner
Sale
Calculated transaction value
$1.13M
24,846 shares @ $45.38
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Orbimed Advisors Llc
10% owner
Sale
Calculated transaction value
$35.72M
787,024 shares @ $45.38
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Collins Helen Louise
Chief Medical Officer
Sale
Calculated transaction value
$114.02K
2,599 shares @ $43.87
Traded
Jun 17, 2026
Filed
Jun 22, 2026